A study run by the National Institutes of Health showed on Wednesday that people who got Johnson & Johnson Inc’s (JNJ.N) COVID-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer Inc (PFE.N)/BioNTech SE or Moderna Inc (MRNA.O). The study, which is preliminary